Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 18-Jul-23 8:27 PM View:  | Syros Pharmaceuticals, Inc. (SYRS) | 17-Jul-23 | Market Sale (Planned) | 689 | $3.50 | $2,411.50 | (9%) 7.35K to 6.66K | 3% |
| 04-Apr-23 6:54 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 03-Apr-23 | Payment of Exercise | 623 | $2.58 | $1,607.34 | (8%) 7.97K to 7.35K | |
| 04-Apr-23 6:54 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 31-Mar-23 | Option Exercise | 2,000 | -- | -- | 33% 5.97K to 7.97K | |
| 04-Apr-22 5:02 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 01-Apr-22 | Payment of Exercise | 27,266 | $1.12 | $30,537.90 | (31%) 87.0K to 59.73K | |
| 06-Jan-22 5:02 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 05-Jan-22 | Market Sale (Planned) | 2,208 | $3.47 | $7,654.92 | (100%) 2.21K to 0 | (2%) |
| 17-Mar-21 5:10 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 15-Mar-21 | Option Exercise | 3,628 | $1.01 | $3,664.28 | 100% 0 to 3.63K | |
| 17-Mar-21 5:10 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 15-Mar-21 | Market Option Sale (Planned) | 3,628 | $9.47 | $34,371.70 | (100%) 3.63K to 0 | |
| 19-Aug-20 4:35 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 18-Aug-20 | Option Exercise | 10,787 | $1.01 | $10,894.90 | 100% 0 to 10.79K | |
| 19-Aug-20 4:35 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 18-Aug-20 | Market Option Sale (Planned) | 10,787 | $13.00 | $140,231.00 | (100%) 10.79K to 0 | 10% |
| 19-Aug-20 4:35 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 17-Aug-20 | Option Exercise | 4,963 | $1.01 | $5,012.63 | 100% 0 to 4.96K | |
| 19-Aug-20 4:35 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 17-Aug-20 | Market Option Sale (Planned) | 4,963 | $13.00 | $64,519.00 | (100%) 4.96K to 0 | 10% |
| 07-Jul-20 7:33 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 07-Jul-20 | Market Sale (Planned) | 1,753 | $11.72 | $20,538.50 | (100%) 1.75K to 0 | < 1% |
| 20-Feb-20 4:15 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 18-Feb-20 | Market Sale (Planned) | 1,446 | $7.38 | $10,674.10 | (100%) 1.45K to 0 | (58%) |
| 14-Feb-19 5:17 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 12-Feb-19 | Grant | 87,000 | -- | -- | 100% 0 to 87.0K | |
| 08-Aug-17 5:20 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 07-Aug-17 | Option Exercise | 2,500 | $1.01 | $2,525.00 | 100% 0 to 2.5K | |
| 08-Aug-17 5:20 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 07-Aug-17 | Market Option Sale (Planned) | 2,500 | $23.59 | $58,969.00 | (100%) 2.5K to 0 | 50% |
| 27-Jul-17 4:09 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 25-Jul-17 | Option Exercise | 12,500 | $1.01 | $12,625.00 | 100% 0 to 12.5K | |
| 27-Jul-17 4:09 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 25-Jul-17 | Market Option Sale (Planned) | 12,500 | $21.85 | $273,125.00 | (100%) 12.5K to 0 | 47% |